These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25752711)

  • 1. Nanomedicines in gastroenterology and hepatology.
    Lamprecht A
    Nat Rev Gastroenterol Hepatol; 2015 Apr; 12(4):195-204. PubMed ID: 25752711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Artificial Intelligence to Gastroenterology and Hepatology.
    Le Berre C; Sandborn WJ; Aridhi S; Devignes MD; Fournier L; Smaïl-Tabbone M; Danese S; Peyrin-Biroulet L
    Gastroenterology; 2020 Jan; 158(1):76-94.e2. PubMed ID: 31593701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine in GI.
    Laroui H; Wilson DS; Dalmasso G; Salaita K; Murthy N; Sitaraman SV; Merlin D
    Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G371-83. PubMed ID: 21148398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging applications of nanomedicine in dermatology.
    Saraceno R; Chiricozzi A; Gabellini M; Chimenti S
    Skin Res Technol; 2013 Feb; 19(1):e13-9. PubMed ID: 22175818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promise of metabolic phenotyping in gastroenterology and hepatology.
    Holmes E; Wijeyesekera A; Taylor-Robinson SD; Nicholson JK
    Nat Rev Gastroenterol Hepatol; 2015 Aug; 12(8):458-71. PubMed ID: 26194948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
    Cabral H; Nishiyama N; Kataoka K
    Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.
    Tian Y; Chen J; Zahtabi F; Keijzer R; Xing M
    Pediatr Pulmonol; 2013 Nov; 48(11):1098-111. PubMed ID: 23997035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicines: The magic bullets reaching their target?
    Flühmann B; Ntai I; Borchard G; Simoens S; Mühlebach S
    Eur J Pharm Sci; 2019 Feb; 128():73-80. PubMed ID: 30465818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.
    Laroui H; Rakhya P; Xiao B; Viennois E; Merlin D
    Dig Liver Dis; 2013 Dec; 45(12):995-1002. PubMed ID: 23660079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lancet Gastroenterology & Hepatology: putting the inside out.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):1. PubMed ID: 28404101
    [No Abstract]   [Full Text] [Related]  

  • 13. "Combo" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy.
    Kemp JA; Shim MS; Heo CY; Kwon YJ
    Adv Drug Deliv Rev; 2016 Mar; 98():3-18. PubMed ID: 26546465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular biology 1996: gastroenterology and hepatology].
    Blum HE
    Praxis (Bern 1994); 1997 Jul; 86(29-30):1172-7. PubMed ID: 9333917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology and gene therapy in gastroenterology and hepatology.
    Blum HE
    Eur J Gastroenterol Hepatol; 1999 Jan; 11(1):1-7. PubMed ID: 10495163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
    Pellish RS; Nasir A; Ramratnam B; Moss SF
    Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds.
    Rivera Gil P; Hühn D; del Mercato LL; Sasse D; Parak WJ
    Pharmacol Res; 2010 Aug; 62(2):115-25. PubMed ID: 20097288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of network medicine in gastroenterology and hepatology.
    Baffy G
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1240-4. PubMed ID: 23932906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future approaches of nanomedicine in clinical science.
    Brewer M; Zhang T; Dong W; Rutherford M; Tian ZR
    Med Clin North Am; 2007 Sep; 91(5):963-1016. PubMed ID: 17826113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal nanomedicines: an emerging field.
    Fenske DB; Chonn A; Cullis PR
    Toxicol Pathol; 2008 Jan; 36(1):21-9. PubMed ID: 18337218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.